1. Home
  2. CGTX vs OPAD Comparison

CGTX vs OPAD Comparison

Compare CGTX & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • OPAD
  • Stock Information
  • Founded
  • CGTX 2007
  • OPAD 2015
  • Country
  • CGTX United States
  • OPAD United States
  • Employees
  • CGTX N/A
  • OPAD N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • OPAD Real Estate
  • Sector
  • CGTX Health Care
  • OPAD Finance
  • Exchange
  • CGTX Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • CGTX 53.4M
  • OPAD 43.7M
  • IPO Year
  • CGTX 2021
  • OPAD N/A
  • Fundamental
  • Price
  • CGTX $1.61
  • OPAD $4.16
  • Analyst Decision
  • CGTX Strong Buy
  • OPAD Hold
  • Analyst Count
  • CGTX 3
  • OPAD 5
  • Target Price
  • CGTX $2.83
  • OPAD $2.41
  • AVG Volume (30 Days)
  • CGTX 8.1M
  • OPAD 24.2M
  • Earning Date
  • CGTX 11-12-2025
  • OPAD 11-03-2025
  • Dividend Yield
  • CGTX N/A
  • OPAD N/A
  • EPS Growth
  • CGTX N/A
  • OPAD N/A
  • EPS
  • CGTX N/A
  • OPAD N/A
  • Revenue
  • CGTX N/A
  • OPAD $703,352,000.00
  • Revenue This Year
  • CGTX N/A
  • OPAD N/A
  • Revenue Next Year
  • CGTX N/A
  • OPAD $31.90
  • P/E Ratio
  • CGTX N/A
  • OPAD N/A
  • Revenue Growth
  • CGTX N/A
  • OPAD N/A
  • 52 Week Low
  • CGTX $0.22
  • OPAD $0.91
  • 52 Week High
  • CGTX $3.83
  • OPAD $6.35
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 42.22
  • OPAD 55.56
  • Support Level
  • CGTX $1.43
  • OPAD $3.75
  • Resistance Level
  • CGTX $2.60
  • OPAD $5.44
  • Average True Range (ATR)
  • CGTX 0.32
  • OPAD 1.08
  • MACD
  • CGTX -0.17
  • OPAD -0.10
  • Stochastic Oscillator
  • CGTX 10.81
  • OPAD 29.13

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: